|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-7-21
|
|
pubmed:abstractText |
The independent role of HCV genotype 3 (HCV-3) in dyslipidaemia following highly active antiretroviral therapy (HAART) is still unexplored.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
pubmed-author:CarosiGiampieroG,
pubmed-author:CastelnuovoFilippoF,
pubmed-author:CostarelliSilviaS,
pubmed-author:De SilvestriAnnalisaA,
pubmed-author:Di PietroMassimoM,
pubmed-author:EPOKa-A Study Group of the MASTER Cohort,
pubmed-author:LadisaNicolettaN,
pubmed-author:LapadulaGiuseppeG,
pubmed-author:MaseratiRenatoR,
pubmed-author:ParaninfoGiuseppeG,
pubmed-author:PuotiMassimoM,
pubmed-author:TinelliCarmineC,
pubmed-author:TortiCarloC,
pubmed-author:UccelliMaria CristinaMC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
521-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16856626-Adult,
pubmed-meshheading:16856626-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16856626-Cholesterol,
pubmed-meshheading:16856626-Genotype,
pubmed-meshheading:16856626-HIV Infections,
pubmed-meshheading:16856626-HIV-1,
pubmed-meshheading:16856626-Hepacivirus,
pubmed-meshheading:16856626-Hepatitis C,
pubmed-meshheading:16856626-Humans,
pubmed-meshheading:16856626-Triglycerides
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy.
|
|
pubmed:affiliation |
Istituto per le Malattie Infettive e Tropicali, Università di Brescia, Brescia, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
